HLA class II diversity in HIV-1 uninfected individuals from the placebo arm of the RV144 Thai vaccine efficacy trial
© 2015 John Wiley & Sons A/S. The RV144 HIV vaccine trial in Thailand elicited antibody responses to the envelope of HIV-1, which correlated significantly with the risk of HIV-1 acquisition. Human leukocyte antigen (HLA) class II molecules are essential in antigen presentation to CD4 T cells f...
Saved in:
Main Authors: | K. M. Baldwin, P. K. Ehrenberg, A. Geretz, H. A. Prentice, S. Nitayaphan, S. Rerks-Ngarm, J. Kaewkungwal, P. Pitisuttithum, R. J. O'Connell, J. H. Kim, R. Thomas |
---|---|
Other Authors: | Walter Reed Army Institute of Research |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/35634 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial
by: Heather A. Prentice, et al.
Published: (2018) -
Accuracy of clinical diagnosis of dengue episodes in the RV144 HIV vaccine efficacy trial in Thailand
by: Punnee Pitisuttithum, et al.
Published: (2018) -
Letter to the Editor on: The RV144 vaccine regimen was not associated with enhancement of infection
by: Sandhya Vasan, et al.
Published: (2018) -
Machine learning methods enable predictive modeling of antibody feature:function relationships in RV144 vaccinees
by: Ickwon Choi, et al.
Published: (2018) -
Comparison of antibody responses induced by RV144, VAX003, and VAX004 vaccination regimens
by: Chitraporn Karnasuta, et al.
Published: (2018)